| For: | Niu CG, Zhang J, Rao AV, Joshi U, Okolo P. Comparative effectiveness of immunotherapy and chemotherapy in patients with metastatic colorectal cancer stratified by microsatellite instability status. World J Clin Oncol 2024; 15(4): 540-547 [PMID: 38689622 DOI: 10.5306/wjco.v15.i4.540] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v15/i4/540.htm |
| Number | Citing Articles |
| 1 |
Yaqin Wang, Tianxiao Wang, Yuewei Zhang. A Case Report of Pathologically Complete Response of a Huge Lymph Node Metastasis of Colorectal Cancer After Treatment with Intratumoral Oncolytic Virus H101 and Capecitabine. ImmunoTargets and Therapy 2024; doi: 10.2147/ITT.S470018
|
| 2 |
Srija Roy, Tathagata Jha, Mrinal K. Ghosh. Personalized Cancer Therapy. 2026; doi: 10.1007/978-981-95-6845-1_2
|
| 3 |
Ahmed Abdelrafee, Ibrahem Lotfy Abulazm, Amr Sanad, Tarek Salah, Amgad Fouad, Rene Adam. Neoadjuvant chemotherapy for upfront resectable colorectal liver metastasis: Is it worthwhile?. Clinical Surgical Oncology 2026; 5(3) doi: 10.1016/j.cson.2026.100142
|
| 4 |
Lidia Kwiatkowska, Małgorzata Szczuko. The Role of Monoclonal Antibody Targeted Therapy (Panitumumab) in the Treatment of Metastatic Colorectal Cancer—A Narrative Review of Current Evidence and Emerging Therapeutic Strategies. International Journal of Molecular Sciences 2026; 27(17) doi: 10.3390/ijms27177559
|
| 5 |
Sarah Benammi, Youssef Mahdi, Achour Youssef, Salma Kachkach, Ichou Mohamed, Benkabbou Amine. Beyond the image: achieving complete pathologic response in MSI-high metastatic colon cancer despite persistent PET activity. International Journal of Surgery Case Reports 2026; 138(5) doi: 10.1097/RC9.0000000000000319
|
| 6 |
Mohamad Mourad, Nada Assaf, Layal Al Mahmasani, Rami Mahfouz, Najla Fakhruddin, Ali Shamseddine. Durable response to dual immune checkpoint blockade in Lynch syndrome–associated serous ovarian carcinoma: a case report. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1868646
|
| 7 |
Caihao Qu, Xin YAN, Yumin Li. ZP3 promotes hepatocellular carcinoma progression via the Notch signaling pathway and is associated with the tumor microenvironment and immunotherapy response. World Journal of Surgical Oncology 2026; 24(1) doi: 10.1186/s12957-026-04245-2
|
| 8 |
Yudith Annisa Ayu Rezkitha, Amal Arifi Hidayat, Irene Normalina, Ricky Indra Alfaray, Priyo Budi Purwono, Maria Inge Lusida, Brahmana Askandar Tjokroprawiro, Isna Mahmudah, Hasan Maulahela, Yoshio Yamaoka, Muhammad Miftahussurur. Profiling gut microbiota of colorectal cancer in Indonesia: a focus on beneficial taxa depletion. Gut Pathogens 2026; 18(1) doi: 10.1186/s13099-026-00816-6
|
| 9 |
J.E.M. van Dommelen, H. Gardarsdottir, T.C.G. Egberts, T.J. Giezen. Drug exposure definitions reported in real-world evidence studies on oncology medicines in patients with colorectal cancer: a scoping review. ESMO Real World Data and Digital Oncology 2026; 13 doi: 10.1016/j.esmorw.2026.100750
|
| 10 |
M Staninova-Stojovska, N Matevska-Geshkovska, E Krstevska-Bozhinovikj, R Jovanovic, K Kubelka Sabit, B Angelovska, N Mitreski, P Noveski, A Dimovski. Qualitative and Quantitative Aspects of Discrepancies between Various Methods for Microsatellite Instability Detection. Balkan Journal of Medical Genetics 2025; 28(1) doi: 10.2478/bjmg-2025-0009
|
| 11 |
Peijue Wang, Yongxiang Li. Development and validation of a prognostic model based on T cell signature genes in colon cancer using single-cell RNA sequencing. Clinical and Experimental Medicine 2026; 26(1) doi: 10.1007/s10238-025-01994-4
|
| 12 |
Yu Sun, Yandong Li, Haopeng Jiang, Xueyan Liu, Shuai Yu, Yuqi Liu. Beyond the barrier: Engineering the tumor-immune-soil nexus–a mechanistic blueprint for integrating Traditional Chinese Medicine with immunotherapy in metastatic colorectal cancer. Medical Oncology 2026; 43(10) doi: 10.1007/s12032-026-03397-1
|